Header Logo

Connection

SHUBHAM PANT to Ipilimumab

Back to Details
This is a "connection" page, showing publications SHUBHAM PANT has written about Ipilimumab.
SHUBHAM PANT
Connection Strength
0.139
Ipilimumab
  1. A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies. Clin Cancer Res. 2021 06 01; 27(11):3050-3060.
    View in: PubMed
    Score: 0.139
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.